Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event

Aims: The J-STARS study examined whether pravastatin (10 mg/day) reduces recurrence of stroke in non-cardioembolic ischemic stroke patients who were enrolled within 1 month to 3 years after initial stroke events (ClinicalTrials.gov, NCT00221104). The main results showed that the frequency of atherot...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Atheroscler Thromb
Главные авторы: Hosomi, Naohisa, Nagai, Yoji, Kitagawa, Kazuo, Nakagawa, Yoko, Aoki, Shiro, Nezu, Tomohisa, Kagimura, Tatsuo, Maruyama, Hirofumi, Origasa, Hideki, Minematsu, Kazuo, Uchiyama, Shinichiro, Matsumoto, Masayasu
Формат: Artigo
Язык:Inglês
Опубликовано: Japan Atherosclerosis Society 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868512/
https://ncbi.nlm.nih.gov/pubmed/28924103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.40196
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы